Fate Therapeutics Inc. (FATE) Declined -6.11% or -1.16 To Price $17.89 On Thursday


Fate Therapeutics Inc. (FATE) declined -6.11% or -1.16 to $17.89. It is close to 286254 shares traded, which is 35.35% compare to the average total volume 809780. The market cap of FATE is $1.17 billion. The year to date change is 34.76%. The 52 week price range is from $8.64 to $20.65. Price of FATE have changed -4.41% during last week. It have changed 6.42% over last month, 18.90% over last 3 months, 21.09% over last 6 months and 67.34% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for FATE is 17.71. It is -1.01% below current price. The 200-day Moving Averages for FATE is 15.20. It is -15.04% below current price. The 52-week High is 20.65. It is 15.43% from the current price. The 52-week Low is 8.64. It is -51.70% from current price.

There are some statistics of FATE. It is has market cap $1.17 billion. The share outstanding is 65.19 million. The average volume is 809780. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of FATE is -70.45%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of FATE is -47.21%.


Tags:

Share this post